Gregory Barton

Dr. Gregory Barton

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
DRDavid R. Rutkowski
David R. Rutkowski
GBGregory Barton
Gregory Barton
CFChristopher J. François
Christopher J. François
NANiti Aggarwal
Niti Aggarwal
ARAlejandro Roldán-Alzate
Alejandro Roldán-Alzate
Left ventricular blood flow vorticity metrics were observed to be higher in women than in men and displayed moderate correlation to cardiac strain metrics; the methods and results of this study may... PurposeTo further understand the relationship between cardiac function and flow, on the basis of sex, by quantifying cardiac flow characteristics and relating them to cardiac muscle performance in ...

1 March 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
AMAshley Mulchrone
Ashley Mulchrone
ABAlessandro Bellofiore
Alessandro Bellofiore
JDJohannes Menno Douwes
Johannes Menno Douwes
NDNeal Duong
Neal Duong
ABArij G. Beshish
Arij G. Beshish
NCNaomi C. Chesler
Naomi C. Chesler

1 December 2022 in Radiology
Verified
Journal Article
Closed access
AHAndrew D. Hahn
Andrew D. Hahn
KCKatie J. Carey
Katie J. Carey
GBGregory Barton
Gregory Barton
LTLuis A. Torres
Luis A. Torres
JKJeff Kammerman
Jeff Kammerman
SFSean Fain
Sean Fain
In a prospective study, reduced lung function at hyperpolarized 129Xe MRI and extent of fibrotic structure at CT were associated with disease progression in idiopathic pulmonary fibrosis 1 year later. Background Idiopathic pulmonary fibrosis (IPF) is a temporally and spatially heterogeneous lung disease. Identifying whether IPF in a patient is progressive or stable is crucial for treatment regim...

10 March 2022 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
LTLuis A. Torres
Luis A. Torres
KLKristine E. Lee
Kristine E. Lee
GBGregory Barton
Gregory Barton
AHAndrew D. Hahn
Andrew D. Hahn
NSNathan Sandbo
Nathan Sandbo
SFSean Fain
Sean Fain
Background: The objective of this work was to apply quantitative and semiquantitative dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) methods to evaluate lung perfusion in idiopathic pulmonary fibrosis (IPF).Methods: In this prospective trial 41 subjects, including healthy control and IPF subjects, were studied using DCE-MRI at baseline. IPF subjects were then followed for 1 year; progressive IPF (IPFprog) subjects were distinguished from stable IPF (IPFstable) subjects based on a decline in percent predicted forced vital capacity (FVC % pred) or diffusing capacity of the lung for carbon monoxide (DLCO% pred) measured during follow-up visits. 35 out of 41 subjects were retained for final baseline analysis (control: n=15; IPFstable: n=14; IPFprog: n=6). Seven measures and their coefficients of variation (CV) were derived using temporally resolved DCE-MRI. Two sets of global and regional comparisons were made: controlversusIPF groups and controlversusIPFstableversusIPFproggroups, using linear regression analysis. Each measure was compared with FVC % pred,DLCO% pred and the lung clearance index (LCI % pred) using a Spearman rank correlation.Results: DCE-MRI identified regional perfusion differences between control and IPF subjects using first moment transit time (FMTT), contrast uptake slope and pulmonary blood flow (PBF) (p≤0.05), while global averages did not. FMTT was shorter for IPFprogcompared with both IPFstable(p=0.004) and control groups (p=0.023). Correlations were observed between PBF CV andDLCO% pred (rs= −0.48, p=0.022) and LCI % pred (rs= +0.47, p=0.015). Significant group differences were detected in age (p<0.001),DLCO% pred (p<0.001), FVC % pred (p=0.001) and LCI % pred (p=0.007).Conclusions: Global analysis obscures regional changes in pulmonary haemodynamics in IPF using DCE-MRI in IPF. Decreased FMTT may be a candidate marker for IPF progression.

10 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GBGregory Barton
Gregory Barton
PCPhilip Corrado
Philip Corrado
Christopher FrancoisChristopher Francois
Christopher Francois
NCNaomi C. Chesler
Naomi C. Chesler
MEMarlowe Eldridge
Marlowe Eldridge
KGKara Goss
Kara Goss
Individuals born prematurely have smaller hearts, cardiac limitations to exercise, and increased overall cardiometabolic risk. The cardiac effects of acute hypoxia exposure as another physiologic stressor remain under explored. The purpose of this study was to determine the effects of hypoxia on ventricular function in adults born preterm. Adults born moderately to extremely preterm (≤32 weeks gestation or <1500 g, N = 32) and born at term (N = 18) underwent cardiac magnetic resonance imaging under normoxic (21% O2) and hypoxic (12% O2) conditions to assess cardiovascular function. In normoxia, cardiac function parameters were similar between groups. During hypoxia, the right ventricular (RV) contractile response was significantly greater in participants born premature, demonstrated by greater increases in RV ejection fraction (EF) (p = 0.002), ventricular-vascular coupling (VVC) (p = 0.004), and strain (p < 0.0001) measures compared to term-born participants, respectively. Left ventricular contractile reserve was similar to term-born participants. Adults born preterm exhibit an exaggerated contractile response to acute hypoxia, particularly in the RV. This suggests that adults born preterm may have contractile reserve, despite the lack of volume reserve identified in previous exercise studies. However, this exaggerated and hyper-adapted response may also increase their risk for late RV failure.

20 June 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
KMKent J. MacLaughlin
Kent J. MacLaughlin
GBGregory Barton
Gregory Barton
RBRudolf K. Braun
Rudolf K. Braun
JMJulia E. MacLaughlin
Julia E. MacLaughlin
JLJacob J. Lamers
Jacob J. Lamers
MEMarlowe W. Eldridge
Marlowe W. Eldridge
Introduction: Hyperbaric air (HBA) was first used pharmaceutically in 1662 to treat lung disease. Extensive use in Europe and North America followed throughout the 19th century to treat pulmonary and neurological disorders. HBA reached its zenith in the early 20th century when cyanotic, moribund “Spanish flu pandemic” patients turned normal color and regained consciousness within minutes after HBA treatment. Since that time the 78% Nitrogen fraction in HBA has been completely displaced by 100% oxygen to create the modern pharmaceutical hyperbaric oxygen therapy (HBOT), a powerful treatment that is FDA approved for multiple indications. Current belief purports oxygen as the active element mobilizing stem progenitor cells (SPCs) in HBOT, but hyperbaric air, which increases tensions of both oxygen and nitrogen, has been untested until now. In this study we test HBA for SPC mobilization, cytokine and chemokine expression, and complete blood count.Methods: Ten 34–35-year-old healthy volunteers were exposed to 1.27ATA (4 psig/965 mmHg) room air for 90 min, M-F, for 10 exposures over 2-weeks. Venous blood samples were taken: (1) prior to the first exposure (served as the control for each subject), (2) directly after the first exposure (to measure the acute effect), (3) immediately prior to the ninth exposure (to measure the chronic effect), and (4) 3 days after the completion of tenth/final exposure (to assess durability). SPCs were gated by blinded scientists using Flow Cytometry.Results: SPCs (CD45dim/CD34+/CD133-) were mobilized by nearly two-fold following 9 exposures (p = 0.02) increasing to three-fold 72-h post completion of the final (10th) exposure (p = 0.008) confirming durability.Discussion: This research demonstrates that SPCs are mobilized, and cytokines are modulated by hyperbaric air. HBA likely is a therapeutic treatment. Previously published research using HBA placebos should be re-evaluated to reflect a dose treatment finding rather than finding a placebo effect. Our findings of SPC mobilization by HBA support further investigation into hyperbaric air as a pharmaceutical/therapy.